Navigation Links
Complexities Simplified for Medicare's Mandatory Insurer Reporting
Date:3/12/2009

"Our focus is on enabling claims cost mitigation best practices by developing innovative solutions for our clients," said Brian Thede, CEO of Aon Recovery, a specialized claims cost reduction group within Aon responsible for managing the partnership with Crowe Paradis. "As the fastest-growing and most highly regarded service provider in the space, Crowe Paradis certainly meets our best-in-class standards and adds significantly to Aon's solution set by specifically addressing and simplifying the Medicare Compliance challenge."

A key component of the Aon-Crowe Paradis offering is the MSP Navigator product, designed to manage the entire MIR process for an organization as an outsourced solution. Some of the difficulties that the product can address include:

  • Reporting on MIR-required data that is not found in distinct, searchable fields in claims systems
  • Drawing legacy claims systems within one organization or several claims from several claims organizations together into one repository and one reporting process
  • Determining Medicare eligibility status on claimants in an efficient, large-scale manner
  • Providing visibility on the status of CMS reporting
  • Managing execution reporting and consequent interaction with CMS, COB, and MSPRC in order to minimize the impact to claims personnel
  • Discovering, verifying and negotiating conditional liens associated with your organization
  • Providing consistent reporting to CMS, even among the non-workers' compensation parts of a claims organization that lack experience with the MSP statute
  • Identifying cases requiring Medicare Set-Aside arrangements
  • Considering legal issues of both state and federal law through a sophisticated Rules Engine

In addition, the offering includes access to a team of experie
'/>"/>

SOURCE Aon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Less costly, more accessible and as effective: Simplified treatment for sleep apnea
2. SaltCheck Develops First Simplified Test for Monitoring Salt Intake in People With Hypertension
3. A simplified scoring system may predict overall CVD risk, individual CVD components risk
4. New Long-Term Care Insurer Offers Simplified Insurance Plans in Florida
5. System of Simplified, Standardized Dosing Instructions for Prescription Medication Container Labels Proposed at Sixth Annual National Health Communication Conference
6. System of simplified, standardized dosing instructions for prescription drug labels proposed
7. New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs
8. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
9. Consumer Watchdog to U.S. Senate: Dont Leave Consumers Out of Health Reform Debate, Public Opposes Mandatory Purchases of Private Insurance & Supports Opening Medicare to Everyone
10. New Poll Warns Daschle, Obama: Mandatory Health Insurance Big Loser With Public; Voters Want Return on Stem Cell Research
11. Consumer Watchdog Urges President-elect Obama to Continue to Oppose Mandatory Purchase of Junk Health Insurance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Bobby Berk Home & Author and Political An...nual Toy Drive benefiting Providence Hospital&rsqu...gram. The goal is to raise $5000 in cash and toy d...ved, Bobby Berk Home will match the donation. Toys...r 19th at Providence Hospital. , ...
(Date:12/4/2009)... not clear enough to recommend its use, experts sa... -- Cancer patients, glaucoma patients and others ...analysis shows that it can help multiple sclerosis...that are the hallmark of the debilitating autoimmu...nabinoids in MS appears to be comprehensive, and s...
(Date:12/4/2009)...CITY, Calif., Dec. 4 Gen... that the company will present results from five s...r Symposium (SABCS), taking place December 9-13, 2...Four of the studies analyze Onco type DX®, t...cians currently use to predict the likelihood of c...
(Date:12/4/2009)... InhibOx, a leading developer of novel and ef...has joined forces with MolPort, an innovator in ra... rare chemical trading platform and builds databas...ide this database and its updates to computational...o the virtual screening procedures. Once they iden...
(Date:12/4/2009)... Plantar fasciitis heel pain affects over two ... cold therapy has been cited by the American Acade...t option. In response to these findings, Orthotic... cold therapy systems for plantar fasciitis treatm...ht splint therapies. , (P...
Breaking Medicine News(10 mins):Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2Health News:Review Finds Marijuana May Help MS Patients 2Health News:Review Finds Marijuana May Help MS Patients 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 2Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 4Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2
...nd that people who were in their sixties have beco.../. This resulted in an increase in the rates of co... their parts in creating awareness among the proce...over the last year. The most sort after cosmet...
...rs at the National Institutes of Health (NIH) and ...CDC), diagnosed the prevalence of diabetes in U.S....s risen from about 5.1 percent to 6.5 percent, fro... the people with diabetes (i.e. about 2.8 percent ...
...tice to the Centre asking it to explain the basis ...t reservation was taken//. With the deadlock ...oday decided to examine the government's controver...asis on which government decided to go ahead with ...
...om type 1 diabetes to alopecia, from which the imb...m, autoimmune disease can be understood//. By ...thyroid, yeast infection of the skin and/or mucous...ses in a lifetime. The same mutation causes a ...
...ministration in WHO, to an agreement that will per... This is indeed a quantum leap in this field, whic...reover, it will also infuse renewed thrust in the ...is being considered as a breakthrough by the healt...
...rld statistics regarding the use of tobacco amongs... in five 13-15 year olds consume tobacco and its p...n the run up to the World Health Organization's Wo...g cigarette smoking in any form is extremely injur...
Other Medicine News:Health News:Adult Diabetics Were Unaware Of Their Condition 2Health News:Supreme Court Verdict Gives Hope to Striking Medicos 2Health News:Autoimmune Diseases – Newer Preventive Measure 2Health News:Autoimmune Diseases – Newer Preventive Measure 3
(Date:12/3/2009)...wire/ -- ParagonRx, a Delaware-based company speci...mal medication use, will host a free webinar on We...MS - Risk Evaluation Mitigation Strategy - program...nt. Dr. Gary Slatko, chief medical officer of Par...rograms, will lead the one-hour program beginning ...
(Date:12/3/2009)...stCall/ -- Cardium Therapeutics (NYSE Amex: CXM )... Tissue Repair Company, submitted a 510(k) premark... Administration (FDA) seeking marketing clearance ... positive data from the Company,s recently complet...sion with the FDA covers Excellagen XL(TM) and Ex...
(Date:12/3/2009)...RNewswire-FirstCall/ -- Each year, hundreds of und...(U.S.) and Europe participate in the Amgen Scholar...nder renowned faculty members at the world,s leadi...present and future - will have exclusive access to...scholars.com . ,, "The new Web site is designe...
Breaking Medicine Technology:Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Medco to Present at November 2009 Investor Conferences 5692 1Medco to Present at November 2009 Investor Conferences 5692 2LA BioMed researcher to be honored 60089 1LA BioMed researcher to be honored 60089 2Science at the petascale 3A Roadrunner results unveiled 60085 1Science at the petascale 3A Roadrunner results unveiled 60085 2Science at the petascale 3A Roadrunner results unveiled 60085 3
...Mar 22, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB...f the analysis of results from the Company,s phase.... The clinical,direction for AEOL 10150 is current...ts for an efficacy study as a protector of healthy...head and neck,cancer and Amyotrophic Lateral Scler...
...--Mar 22, 2007 - FzioMed,Inc. announced today tha...thetic dermal fillers is being presented at the,An...arlo March,22-24, 2007., In 2006, FzioMed launched...n-permanent, synthetic filler created from the,com...s a completely,new class of filler for the correct...
Other Medicine Technology:Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 2Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 3Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 4Laresse Dermal Filler Research Presented at Anti-Aging World,Congress 2
RABIT
Albumin Reagent Set
AST (SGOT)
AST (GOT) + Starter Reagent
Medicine Products: